ALTRAPHARMA Invest ApS: Financial statements 2021
CVR: 34483884
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -76,082 and a net result of DKK -145,775 compared with DKK 407,135 the year before. Equity in the 2021 report amounted to DKK 553,679. The solvency ratio was 68.6%.
- Gross Profit
- DKK -76,082
- Profit/Loss
- DKK -145,775
- Equity
- DKK 553,679
- Total Assets
- DKK 807,626
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -76 t. | -146 t. | 554 t. | 0 |
| 2020 | - | 527 t. | 407 t. | 699 t. | 0 |
| 2019 | - | 158 t. | 110 t. | 292 t. | 0 |
| 2017 | - | 473 t. | 270 t. | 517 t. | 0 |
| 2016 | - | 1.2 mio. | 67 t. | 247 t. | 0 |
Official annual report
Find more companies like ALTRAPHARMA Invest ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout ALTRAPHARMA Invest ApS
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.